Sign in with Google. Opens in new tab
bullish

PYC Therapeutics Limited - Net Positive VP-001 Update at APVRS

175 Views02 Dec 2024 23:24
Broker
Given our confidence on the safety profile of VP-001 we maintain our price target of $2.40 (VP-001 $0.90, ADPKD $0.90, ADOA $0.40 and PMS $0.20).
What is covered in the Full Insight:
  • Introduction to VP-001 and RP11
  • Phase I/II Dataset Update
  • Analysis of LLVA and Microperimetry Data
  • Upcoming Clinical Trial Design and FDA Meeting
  • Forecasts, Valuation, and Investment Recommendation
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 27-minute read)
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • PYC Therapeutics Limited - Net Positive VP-001 Update at APVRS
    02 Dec 2024
x